Inhibitor Binding to Type 4 Phosphodiesterase (PDE4) Assessed Using [3H]Piclamilast and [3H]Rolipram-Reference-Cited by-同舟云学术

Inhibitor Binding to Type 4 Phosphodiesterase (PDE4) Assessed Using [3H]Piclamilast and [3H]Rolipram

Published:2003-01-24 Issue:2 Volume:305 Page:565-572
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Zhao Yu,Zhang Han-Ting,O'Donnell James M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference50 articles.

1. Development of a recombinant cell-based system for the characterisation of phosphodiesterase 4 isoforms and evaluation of inhibitors

2. Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs

3. Phosphodiesterase 4 Conformers: Preparation of Recombinant Enzymes and Assay for Inhibitors

4. Association of the anti-inflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [3H]rolipram binding

5. Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site.;Barnette;J Pharmacol Exp Ther,1995

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond PDE4 inhibition: A comprehensive review on downstream cAMP signaling in the central nervous system;Biomedicine & Pharmacotherapy;2024-08

2. FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes;Journal of Cystic Fibrosis;2023-05

3. Potential PDE4B inhibitors as promising candidates against SARS‐CoV‐2 infection;Biomolecular Concepts;2023-01-01

4. FDA-Approved Drug Screening in Patient-Derived Organoids Demonstrates Potential of Drug Repurposing for Rare Cystic Fibrosis Genotypes;2022-09-03

5. Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice;Biology;2021-12-20